Protecting Medical Innovation Protects Patient Access
Scientific breakthroughs and innovative medicines offer new promise for millions of patients battling life threatening cancers, Alzheimer’s and global pandemics.
Clinical Trials Access Barriers Delay & Derail New Treatments
Making Clinical Trials Access a Global Priority
Excesso na legislação para vacinas contra a COVID no Brasil
With more than a half million Brazilians dead from COVID-19, the country’s legislators are scrambling to improve vaccine access. But their newest efforts could have unintended consequences for patients.
Brazil’s COVID Vaccine Overreach
With more than a half million Brazilians dead from COVID-19, the country’s legislators are scrambling to improve vaccine access. But their newest efforts could have unintended consequences for patients.
Patents, Patients & COVID-19
World leaders are squaring off on a complex topic: whether to temporarily waive intellectual property rights for COVID-19 vaccines.
Europe Gets Real on Health Care Evidence
A new organisation aims to fill the gap between health care data and health care reality. How? By embracing real-world evidence.
The Vaccines That Can Bring Us Closer
Just as COVID-19 drove people to distance themselves, widespread vaccination has the potential to bring them closer. But as the World Health Organization celebrates World Immunization Week, COVID-19 vaccination across Europe remains a challenge.
Youth Advocates Aren’t Waiting to Shape Health Policy
In Europe, young patients and health care professionals have decided that now is the time to seek better health policies. I saw this first-hand at February’s #RARE2030 rare disease policy conference.
Setting the Record Straight on COVID-19 Vaccines
European citizens have questions about the COVID-19 vaccines. Are they safe? Will they work? What about side effects? Answers to those questions are emerging, in part due to the efforts of the European Medicines Agency.
